Since its establishment in 2021, Shanghai Surzyme Biotechnology Co., Ltd. has remained dedicated to deep technical development and product innovation in recombinant enzymes and recombinant proteins. From a start-up team to large-scale production, the Company has grown steadily, one step at a time. The following are key milestones in its development.
Shanghai Surzyme Biotechnology Co., Ltd. was formally established, setting recombinant enzyme and recombinant protein technology as its core direction and forming its founding R&D team.
The core phospholipase D series achieved stable mass production; with high activity and green enzymatic processes, the Company formally entered the in vitro diagnostics (IVD) raw materials market.
Formally passed ISO 9001:2015 quality management system certification (Certificate No. 19826Q00193R0S1), bringing quality management to a new level.
The product line surpassed 112+ SKUs, covering molecular diagnostics, industrial catalysis, and aesthetic medicine raw materials, with steadily growing large-scale supply capability.
The Company received provincial-level SRDI enterprise certification, with its brand and technical capabilities highly recognized. It simultaneously launched an international market strategy and stepped onto the global stage.
surzyme